Transition of apoptotic resistant vascular smooth muscle cells to troptotic sensitive state is correlated with downregulation of c-FLIP

被引:16
作者
Imanishi, T
Hano, T
Nishio, I
Liles, WC
Schwartz, SM
Han, DKM
机构
[1] Wakayama Med Coll, Dept Med, Div Cardiol, Wakayama 6418510, Japan
[2] Univ Washington, Dept Med, Seattle, WA USA
[3] Univ Washington, Dept Pathol, Seattle, WA 98195 USA
[4] Univ Washington, Dept Mol Biotechnol, Seattle, WA 98195 USA
关键词
apoptosis; vascular smooth muscle cell; c-FLIP; Fas signaling; protein inhibitor;
D O I
10.1159/000054085
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Fas and its ligand, FasL, are a receptor-ligand pair identified as promoting cell death in several tissues. Vascular smooth muscle cells (VSMCs) are resistant to FasL or anti-Pas antibody (Ab) signal, and a number of in vitro studies show that VSMC death can only be induced by anti-Pas Ab or FasL in the presence of protein inhibitor or additional inflammatory mediators. It remains to be clarified whether known, constitutively expressed cytoprotective molecules are reduced by protein inhibitor, thereby accounting for sensitization to cell death by Fas/FasL signaling. We found that Pas mRNA and protein exist in several primary VSMCs, as previously reported. We also demonstrated (1) that critical death-signaling molecules, such as FADD, caspase-1/ICE, and caspase-3/YAMA, are present in these VSMCs, (2) that human VSMCs contain high concentrations of c-FLIP (3) and that following treatment with the protein inhibitor, CHX, cell extracts showed a decrease in c-FLIP protein that was dose- and time-dependent on the degree of apoptosis and inversely correlated with both caspase-8 and -3 activity. in contrast, there was neither a change nor an even modest upregulation of Bcl-2 family, even after 12 h of treatment with CHX, Taken together, these results may provide a novel insight into atherogenesis and suggest that c-FLIP may contribute to an apoptosis-resistant state of VSMC, and that a downregulation of c-FLIP may render VSMCs susceptible to apoptosis. Copyright (C) 2000 S. Karger AG, Basel.
引用
收藏
页码:523 / 531
页数:9
相关论文
共 31 条
[1]  
Algeciras-Schimnich A, 1999, J IMMUNOL, V162, P5205
[2]   The role of Fas/APO 1 and apoptosis in the development of human atherosclerotic lesions [J].
Cai, WJ ;
Devaux, B ;
Schaper, W ;
Schaper, J .
ATHEROSCLEROSIS, 1997, 131 (02) :177-186
[3]  
Dong CM, 1996, LAB INVEST, V74, P921
[4]   Fas and Fas ligand in embryos and adult mice: Ligand expression in several immune-privileged tissues and coexpression in adult tissues characterized by apoptotic cell turnover [J].
French, LE ;
Hahne, M ;
Viard, I ;
Radlgruber, G ;
Zanone, R ;
Becker, K ;
Muller, C ;
Tschopp, J .
JOURNAL OF CELL BIOLOGY, 1996, 133 (02) :335-343
[5]  
Fukuo K, 1997, GERONTOLOGY, V43, P35
[6]  
GENG YJ, 1995, AM J PATHOL, V147, P251
[7]   Apoptosis of vascular smooth muscle cells induced by in vitro stimulation with interferon-gamma, tumor necrosis factor-alpha, and interleukin-1 beta [J].
Geng, YJ ;
Wu, Q ;
Muszynski, M ;
Hansson, GK ;
Libby, P .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1996, 16 (01) :19-27
[8]   Fas is expressed in human atherosclerotic intima and promotes apoptosis of cytokine-primed human vascular smooth muscle cells [J].
Geng, YJ ;
Henderson, LE ;
Levesque, EB ;
Muszynski, M ;
Libby, P .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1997, 17 (10) :2200-2208
[9]   CASH, a novel caspase homologue with death effector domains [J].
Goltsev, YV ;
Kovalenko, AV ;
Arnold, E ;
Varfolomeev, EE ;
Brodianskii, VM ;
Wallach, D .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (32) :19641-19644
[10]   FAS LIGAND-INDUCED APOPTOSIS AS A MECHANISM OF IMMUNE PRIVILEGE [J].
GRIFFITH, TS ;
BRUNNER, T ;
FLETCHER, SM ;
GREEN, DR ;
FERGUSON, TA .
SCIENCE, 1995, 270 (5239) :1189-1192